Highlights and Quick Summary
- Operating Income Growth for the quarter ending December 31, 2022 was -16.03% (a -419.32% decrease compared to previous quarter)
- Year-over-year quarterly Operating Income Growth decreased by -282.57%
- Annual Operating Income Growth for 2022 was -31.32% (a -51.2% decrease from previous year)
- Annual Operating Income Growth for 2021 was -64.18% (a -84.74% decrease from previous year)
- Annual Operating Income Growth for 2020 was -420.6% (a -426.45% decrease from previous year)
- Twelve month Operating Income Growth ending December 31, 2022 was -6.26% (a -47.75% decrease compared to previous quarter)
- Twelve month trailing Operating Income Growth decreased by -81.76% year-over-year
Trailing Operating Income Growth for the last four month:
| 31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
|---|---|---|---|
| -6.26% | -11.98% | -31.32% | -34.32% |
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Operating Income Growth of Benitec Biopharma Limited
Most recent Operating Income Growthof BNTC including historical data for past 10 years.Interactive Chart of Operating Income Growth of Benitec Biopharma Limited
Benitec Biopharma Limited Operating Income Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | -16.03% | 5.02% | -22.91% | 8.78% | -31.32% |
| 2021 | -48.36% | -79.26% | -33.22% | -79.68% | -64.18% |
| 2020 | -179.5% | -21.53% | -485.48% | 44.34% | -420.6% |
| 2019 | – | – | – | 64.22% | 128.84% |
| 2018 | – | – | – | – | -119.34% |
| 2017 | – | – | – | 17.71% | 73.77% |
| 2016 | – | – | – | 125.94% | -78.13% |
| 2015 | – | – | – | – | -28.92% |
| 2014 | – | – | – | – | -88.08% |
| 2013 | – | – | – | – | 46.83% |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology